Clinical Trials Logo

Tobacco Use Disorder clinical trials

View clinical trials related to Tobacco Use Disorder.

Filter by:

NCT ID: NCT00690924 Completed - Lung Cancer Clinical Trials

Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer

Start date: July 17, 2008
Phase: N/A
Study type: Interventional

RATIONALE: Calcitriol may prevent lung cancer in patients with metaplasia or dysplasia of the lungs. PURPOSE: This clinical trial is studying the side effects and best dose of calcitriol in preventing lung cancer in current smokers and former smokers at high risk of lung cancer.

NCT ID: NCT00682474 Completed - Nicotine Dependence Clinical Trials

School Nurse-Delivered Smoking Cessation Intervention

Start date: September 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to conduct a randomized controlled school-based trial to evaluate the effectiveness of a four-session school nurse-delivered smoking cessation intervention in increasing abstinence rates among high school students who smoke.

NCT ID: NCT00670995 Completed - Clinical trials for Tobacco Use Disorder

Tobacco Zero: Interactive Tobacco Education for Teens

Start date: November 2009
Phase: Phase 2
Study type: Interventional

There have been a number of tobacco prevention programs developed and tested in the past few years, and some of the comprehensive programs have been promoted by the Office on Smoking and Health at the Centers for Disease Control (CDC). However, the use of these programs and integration into school-based curriculum has been lacking due to a number of factors. We are proposing to develop an interactive computer-based program for tobacco prevention aimed at middle school students. The CD-ROM is designed to be an adjunct to the existing health education curriculum provided for 6th through 8th grade students.

NCT ID: NCT00670904 Completed - Smoking Clinical Trials

Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation

Start date: October 2005
Phase: N/A
Study type: Interventional

This randomized trial compared the effectiveness of a three session pharmacist-delivered group program for smoking versus one 5 to 10 minute standard care session delivered over the telephone on 7-day point prevalence quit rates. Participants in both groups were offered their choice of bupropion IR or nicotine patch at no cost. At 6 months after the established quit date, self-reported cessation was biochemically verified using tests for urinary cotinine.

NCT ID: NCT00666978 Completed - Lung Cancer Clinical Trials

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Start date: December 2007
Phase: Phase 4
Study type: Interventional

RATIONALE: A stop-smoking plan that includes health education counseling and bupropion may help African-American smokers stop smoking. It is not yet known whether health education counseling is more effective with or without bupropion in helping African Americans stop smoking. PURPOSE: This clinical trial is studying health education counseling and bupropion to see how well they work compared with a placebo and health education counseling in helping African Americans smokers stop smoking.

NCT ID: NCT00664755 Completed - Nicotine Dependence Clinical Trials

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

Start date: July 2007
Phase: Phase 2
Study type: Interventional

This is a brief smoking cessation trial in women, comparing transdermal nicotine patch (TNP) versus varenicline.

NCT ID: NCT00664261 Completed - Clinical trials for Tobacco Use Disorder

Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking

Start date: September 2007
Phase: N/A
Study type: Interventional

RATIONALE: The Clinical Effort Against Secondhand Smoke (CEASE) program may be more effective than standard care in increasing the number of parents who stop smoking. PURPOSE: This randomized clinical trial is studying how well the CEASE program works compared with standard care in helping parents stop smoking.

NCT ID: NCT00644137 Completed - Nicotine Dependence Clinical Trials

GABA (Gamma Amino Butyric Acid) Medication for Tobacco

Start date: August 2007
Phase: Early Phase 1
Study type: Interventional

The goal of this study is to examine the effects of a GABA (gamma amino butyric acid)-enhancing medication, pregabalin (300 mg/day), on smoking behavior, tobacco withdrawal and cigarette craving in smokers. We hypothesize that in smokers, pregabalin at 300 mg/day, will be more effective than placebo in decreasing smoking behavior and attenuating tobacco withdrawal and cigarette craving.

NCT ID: NCT00627185 Completed - Clinical trials for Tobacco Use Disorder

Dental Tobacco Control.Net:Improving Practice

DTC
Start date: September 2003
Phase: Phase 0
Study type: Interventional

This is a randomized, controlled trial (RCT) to test the efficacy of an internet continuing dental education intervention designed to increase tobacco cessation counseling in dental practices. The intervention involves surveying practices regarding preventive care, surveying adult patients about their tobacco habits and preventive care provided by dental practice and training/educating the dentist and office staff on tobacco cessation. With patients who smoke and indicate that they have quit, we followed up with testing their saliva for the presence of cotinine. We have enrolled general dentists and periodontists who practice in the Southeastern United States.

NCT ID: NCT00625131 Completed - Clinical trials for Tobacco Use Disorder

Nicotine Patch Pretreatment for Smoking Cessation in PTSD

Start date: May 2008
Phase: Phase 0
Study type: Interventional

This study seeks to evaluate the relationship between PTSD, abstinence, and factors associated with relapse in the context of a randomized, clinical smoking cessation trial.